Trade Report: Today: Daiwa SB Investments Ltd. decides to keep it stake in Walgreens Boots Alliance Inc. (WBA) to the level of $6,770,000

Today: Daiwa SB Investments Ltd. decides to keep it stake in Walgreens Boots Alliance Inc. (WBA) to the level of $6,770,000

Daiwa SB Investments Ltd. increased its position in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 13.5% during the third quarter, Holdings Channel reports. The institutional investor owned 83,980 shares of the pharmacy operator’s stock after buying an additional 9,990 shares during the period. Walgreens Boots Alliance makes up 1.7% of Daiwa SB Investments Ltd.’s portfolio, making the stock its 25th largest position. Daiwa SB Investments Ltd.’s holdings in Walgreens Boots Alliance were worth $6,770,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Grassi Investment Management boosted its position in Walgreens Boots Alliance by 5.1% in the third quarter. Grassi Investment Management now owns 34,318 shares of the pharmacy operator’s stock worth $2,767,000 after buying an additional 1,676 shares in the last quarter. First Financial Bank N.A. Trust Division boosted its position in Walgreens Boots Alliance by 5.7% in the third quarter. First Financial Bank N.A. Trust Division now owns 2,908 shares of the pharmacy operator’s stock worth $234,000 after buying an additional 158 shares in the last quarter. Jacobs & Co. CA boosted its position in Walgreens Boots Alliance by 2.8% in the third quarter. Jacobs & Co. CA now owns 98,845 shares of the pharmacy operator’s stock worth $7,968,000 after buying an additional 2,674 shares in the last quarter. Fisher Asset Management LLC boosted its position in Walgreens Boots Alliance by 4.3% in the third quarter. Fisher Asset Management LLC now owns 6,726 shares of the pharmacy operator’s stock worth $542,000 after buying an additional 277 shares in the last quarter. Finally, Naples Global Advisors LLC boosted its position in Walgreens Boots Alliance by 1.8% in the third quarter. Naples Global Advisors LLC now owns 9,718 shares of the pharmacy operator’s stock worth $784,000 after buying an additional 176 shares in the last quarter. 58.93% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded up 1.09% during trading on Monday, reaching $85.35. 3,952,321 shares of the company were exchanged. Walgreens Boots Alliance Inc. has a 12 month low of $71.50 and a 12 month high of $87.05. The firm has a market capitalization of $92.46 billion, a PE ratio of 22.34 and a beta of 1.19. The stock has a 50 day moving average price of $81.28 and a 200 day moving average price of $81.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.08. The company earned $28.60 billion during the quarter, compared to the consensus estimate of $29.06 billion. Walgreens Boots Alliance had a net margin of 3.56% and a return on equity of 16.33%. Walgreens Boots Alliance’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.88 EPS. On average, analysts expect that Walgreens Boots Alliance Inc. will post $5.01 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 17th will be given a dividend of $0.375 per share. The ex-dividend date of this dividend is Tuesday, November 15th. This represents a $1.50 dividend on an annualized basis and a yield of 1.78%. Walgreens Boots Alliance’s payout ratio is currently 39.27%.

WBA has been the subject of several recent research reports. Robert W. Baird reissued an “outperform” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Tuesday, October 4th. Wells Fargo & Co. initiated coverage on shares of Walgreens Boots Alliance in a report on Monday, October 31st. They set an “outperform” rating for the company. Leerink Swann reissued an “outperform” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Monday, September 19th. Deutsche Bank AG reissued a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a report on Wednesday, September 28th. Finally, Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $90.00 target price for the company in a report on Monday, October 3rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average price target of $90.30.

In other news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $85.00, for a total value of $2,039,660.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Foote sold 2,067 shares of the stock in a transaction dated Wednesday, November 2nd. The shares were sold at an average price of $81.30, for a total transaction of $168,047.10. Following the completion of the transaction, the director now owns 24,623 shares of the company’s stock, valued at approximately $2,001,849.90. The disclosure for this sale can be found here. Company insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Related posts

Leave a Comment